U.S. biotech giant Regeneron chooses Hyderabad to set up GCC
Regeneron Pharmaceuticals Inc. is set to establish a global capability center in Hyderabad, aiming to enhance its global operations. The center is expected to be operational by the second half of 2026 and will create hundreds of jobs as it expands. Hyderabad's reputation as a hub for life sciences and technology talent is a key factor in Regeneron's decision to invest in the region.
- ▪Regeneron Pharmaceuticals Inc. plans to establish its global capability center in Hyderabad.
- ▪The center will be operational in the second half of 2026 and is expected to create hundreds of jobs.
- ▪Hyderabad currently hosts nearly 450 global capability centers and continues to attract international investments.
Opening excerpt (first ~120 words) tap to expand
U.S. biotechnology firm Regeneron Pharmaceuticals Inc. plans to establish its global capability centre (GCC) in Hyderabad.It is a strategic investment decision to deepen global operations and scale business functions. The Regeneron GCC will be operational in the second half of 2026 and is expected to grow to hundreds of jobs in the coming years as it expands capabilities across key global functions, the global biotechnology leader said.The company has 15 approved or authorised medicines and nearly 50 pipeline candidates spanning multiple therapeutic areas and is supported by more than 15,000 employees across North America, Europe and Asia.“Hyderabad has established itself as a world-class hub for Life Sciences and technology talent and we are proud to expand our presence there.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Hindu — Top.
Discussion
0 commentsMore from The Hindu — Top
